Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community

Maruschak, 2009, HIV in prisons, 2007–08

Spaulding, 2009, HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity, PLoS One, 4, e7558, 10.1371/journal.pone.0007558

Cepeda, 2014, Drug abuse and alcohol dependence among inmates, 1147

Mumola, 2006

Altice, 2011

Saber-Tehrani, 2012, Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community — a potential conduit to improved HIV treatment outcomes, Contemp Clin Trials, 33, 436, 10.1016/j.cct.2011.11.002

Springer, 2012, Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners, PLoS One, 7, e38335, 10.1371/journal.pone.0038335

Hammett, 2002, The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997, Am J Public Health, 92, 1789, 10.2105/AJPH.92.11.1789

Springer, 2004, Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community, Clin Infect Dis, 38, 1754, 10.1086/421392

Springer, 2007, Antiretroviral treatment regimen outcomes among HIV-infected prisoners, HIV Clin Trials, 8, 205, 10.1310/hct0804-205

Meyer, 2014, Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate, JAMA Intern Med, 174, 721, 10.1001/jamainternmed.2014.601

Stephenson, 2005, Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals, Public Health Rep, 120, 84, 10.1177/003335490512000114

Baillargeon, 2009, Accessing antiretroviral therapy following release from prison, JAMA, 301, 848, 10.1001/jama.2009.202

Meyer, 2013, Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities, Clin Infect Dis, 57, 1309, 10.1093/cid/cit427

Fu, 2013, Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail, AIDS Behav, 17, S145, 10.1007/s10461-013-0590-1

Binswanger, 2011, Risk factors for all-cause, overdose and early deaths after release from prison in Washington state, Drug Alcohol Depend, 117, 1, 10.1016/j.drugalcdep.2010.11.029

Binswanger, 2007, Release from prison—a high risk of death for former inmates, N Engl J Med, 356, 157, 10.1056/NEJMsa064115

Harding-Pink, 1990, Mortality following release from prison, Med Sci Law, 30, 12, 10.1177/002580249003000104

Harding-Pink, 1988, Risk of death after release from prison: a duty to warn, BMJ, 297, 596, 10.1136/bmj.297.6648.596

Merrall, 2010, Meta-analysis of drug-related deaths soon after release from prison, Addiction, 105, 1545, 10.1111/j.1360-0443.2010.02990.x

Binswanger, 2013, Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009, Ann Intern Med, 159, 592, 10.7326/0003-4819-159-9-201311050-00005

Krinsky, 2009, Drugs, detention, and death: a study of the mortality of recently released prisoners, Am J Forensic Med Pathol, 30, 6, 10.1097/PAF.0b013e3181873784

Thompson, 2012, Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel, Ann Intern Med, 156, 817, 10.7326/0003-4819-156-11-201206050-00419

Smith-Rohrberg, 2004, Review of corrections-based therapy for opiate-dependent patients: implications for buprenorphine treatment among correctional populations, J Drug Issues, 34, 451, 10.1177/002204260403400210

Springer, 2010, Commentary on Larney (2010): a call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners, Addiction, 105, 224, 10.1111/j.1360-0443.2009.02893.x

Coviello, 2011, A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers, Subst Abus, 33, 48, 10.1080/08897077.2011.609438

Center on Budget and Policy Priorities. The Number of Uninsured Americans is at an All-Time High. Washington, D.C. 2006 Accessed from http://www.cbpp.org/8-29-06health.htm on March 1, 2008.

Chandler, 2009, Treating drug abuse and addiction in the criminal justice system: improving public health and safety, JAMA, 301, 183, 10.1001/jama.2008.976

Gordon, 2014, A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry, Drug Alcohol Depend, 142, 33, 10.1016/j.drugalcdep.2014.05.011

National Institute of Drug Abuse

Kinlock, 2008, A study of methadone maintenance for male prisoners: 3-month postrelease outcomes, Crim Justice Behav, 35, 34, 10.1177/0093854807309111

Springer, 2011, Public health implications for adequate transitional care for HIV-infected prisoners: five essential components, Clin Infect Dis, 53, 469, 10.1093/cid/cir446

Wickersham, 2014, Development of a brief measure of opioid dependence: the rapid opioid dependence screen (RODS), J Correct Health Care, 21, 10.1177/1078345814557513

International Harm Reduction Development Program (IHRD) of the Open Society Institute (OSI), 2008, 1

Scott, 2002, The method of minimization for allocation to clinical trials. A review, Control Clin Trials, 23, 662, 10.1016/S0197-2456(02)00242-8

Kang, 2008, Issues in outcomes research: an overview of randomization techniques for clinical trials, J Athl Train, 43, 215, 10.4085/1062-6050-43.2.215

Tideman, 2007, A randomised controlled trial comparing computer-assisted with face-to-face sexual history taking in a clinical setting, Sex Transm Infect, 83, 52, 10.1136/sti.2006.020776

Caldwell, 2012, Computerized assessment facilitates disclosure of sensitive HIV risk behaviors among African Americans entering substance abuse treatment, Am J Drug Alcohol Abuse, 38, 365, 10.3109/00952990.2012.673663

Azbel, 2013, Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community, PLoS One, 8, e59643, 10.1371/journal.pone.0059643

Amico, 2006, Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers, J Acquir Immune Defic Syndr Hum Retrovirol, 42, 455, 10.1097/01.qai.0000225020.73760.c2

Pettinati, 2004

Tompkins, 2009, Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument, Drug Alcohol Depend, 105, 154, 10.1016/j.drugalcdep.2009.07.001

National Institute on Alcohol Abuse and Alcoholism, 2005

Anton, 2006, Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial, JAMA, 295, 2003, 10.1001/jama.295.17.2003

Copenhaver, 2007, Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence, Am J Drug Alcohol Abuse, 33, 643, 10.1080/00952990701522674

Copenhaver, 2003, Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment, J Psychoactive Drugs, 35, 209, 10.1080/02791072.2003.10400002

Miller, 2004

2013

Springer, 2013, Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community, Contemp Clin Trials, 37, 209, 10.1016/j.cct.2013.12.006

Copersino, 2010, Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures, J Subst Abuse Treat, 38, 60, 10.1016/j.jsat.2009.06.004

Maruschak, 2012

Rich, 2005, Attitudes and practices regarding the use of methadone in US state and federal prisons, J Urban Health, 82, 411, 10.1093/jurban/jti072

Krupitsky, 2010, Long-acting depot formulations of naltrexone for heroin dependence: a review, Curr Opin Psychiatry, 23, 210, 10.1097/YCO.0b013e3283386578

Gastfriend, 2011, Intramuscular extended-release naltrexone: current evidence, Ann N Y Acad Sci, 1216, 144, 10.1111/j.1749-6632.2010.05900.x

Wickersham, 2013, Implementing methadone maintenance treatment in prisons in Malaysia, Bull World Health Organ, 91, 124, 10.2471/BLT.12.109132

Mitchell, 2012, Hepatic safety of injectable extended-release naltrexone in patients with chronic hepatitis C and HIV infection, J Stud Alcohol Drugs, 73, 991, 10.15288/jsad.2012.73.991

Vagenas, 2014, An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone, J Subst Abuse Treat, 47, 35, 10.1016/j.jsat.2014.02.008

Delate, 2000, The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIV, Clin Ther, 22, 1112, 10.1016/S0149-2918(00)80088-0

Amorim, 1998, DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI, Eur Psychiatry, 13, 26, 10.1016/S0924-9338(97)86748-X

Sheehan, 1997, Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P, Eur Psychiatry, 12, 232, 10.1016/S0924-9338(97)83297-X

Lecrubier, 1997, The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI, Eur Psychiatry, 12, 224, 10.1016/S0924-9338(97)83296-8

Wang, 2010, Examining factorial structure and measurement invariance of the Brief Symptom Inventory (BSI)-18 among drug users, Addict Behav, 35, 23, 10.1016/j.addbeh.2009.08.003

Derogatis, 2001

Derogatis, 2001

McLellan, 1992, The Fifth Edition of the Addiction Severity Index, J Subst Abuse Treat, 9, 199, 10.1016/0740-5472(92)90062-S

Rosen, 2000, Consistency of self-administered and interview-based Addiction Severity Index composite scores, Addiction, 95, 419, 10.1046/j.1360-0443.2000.95341912.x

Cacciola, 2007, Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index, Drug Alcohol Depend, 87, 297, 10.1016/j.drugalcdep.2006.09.002

Barbor, 2001

Saunders, 1993, Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II, Addiction, 88, 791, 10.1111/j.1360-0443.1993.tb02093.x

Sobell, 1992, Alcohol abusers' perceptions of the accuracy of their self-reports of drinking: implications for treatment, Addict Behav, 17, 507, 10.1016/0306-4603(92)90011-J

Sobell, 2000, Alcohol Timeline Followback (TLFB), 477

Fisher, 2006, Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients, J Acquir Immune Defic Syndr, 41, 44, 10.1097/01.qai.0000192000.15777.5c

Johnson, 2005, The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field, J Stud Alcohol Suppl, 157, 10.15288/jsas.2005.s15.157